1. Home
  2. AVX vs TVGN Comparison

AVX vs TVGN Comparison

Compare AVX & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avax One Technology Ltd.

AVX

Avax One Technology Ltd.

BUY

Current Price

$3.65

Market Cap

21.7M

Sector

Industrials

ML Signal

BUY

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.81

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AVX
TVGN
Founded
2017
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Blank Checks
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
21.7M
21.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AVX
TVGN
Price
$3.65
$6.81
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
19.7K
9.3K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
92.55
N/A
EPS
N/A
N/A
Revenue
$2,340,811.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3348.10
N/A
52 Week Low
$0.35
$0.14
52 Week High
$6.40
$12.03

Technical Indicators

Market Signals
Indicator
AVX
TVGN
Relative Strength Index (RSI) 58.04 57.35
Support Level $0.50 $6.22
Resistance Level $3.92 $7.42
Average True Range (ATR) 0.35 0.47
MACD 0.06 0.05
Stochastic Oscillator 72.88 90.91

Price Performance

Historical Comparison
AVX
TVGN

About AVX Avax One Technology Ltd.

AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: